| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | - | - | 1.062 | 85.637 | 114.350 | 361.153 | 380.613 |
| Total Income - EUR | - | - | - | - | - | 1.062 | 85.652 | 114.363 | 361.908 | 395.737 |
| Total Expenses - EUR | - | - | - | - | - | 584 | 66.966 | 84.512 | 327.022 | 386.933 |
| Gross Profit/Loss - EUR | - | - | - | - | - | 479 | 18.686 | 29.851 | 34.886 | 8.804 |
| Net Profit/Loss - EUR | - | - | - | - | - | 447 | 16.116 | 28.148 | 31.925 | 6.878 |
| Employees | - | - | - | - | - | 3 | 2 | 2 | 4 | 4 |
Check the financial reports for the company - Advanced Pharma S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | - | - | 383 | 1.258 | 21.673 | 80.849 | 64.214 |
| Current Assets | - | - | - | - | - | 9.623 | 19.542 | 46.793 | 117.030 | 116.793 |
| Inventories | - | - | - | - | - | 8.131 | 2.542 | 7.868 | 73.478 | 94.890 |
| Receivables | - | - | - | - | - | 248 | 2.604 | 7.158 | 9.602 | 15.776 |
| Cash | - | - | - | - | - | 1.244 | 14.396 | 31.767 | 33.951 | 6.127 |
| Shareholders Funds | - | - | - | - | - | 488 | 16.594 | 44.793 | 76.583 | 83.033 |
| Social Capital | - | - | - | - | - | 41 | 40 | 41 | 40 | 40 |
| Debts | - | - | - | - | - | 9.518 | 4.207 | 23.673 | 122.892 | 99.329 |
| Income in Advance | - | - | - | - | - | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4646 - 4646" | |||||||||
| CAEN Financial Year |
4646
|
|||||||||
Comments - Advanced Pharma S.r.l.